We are live on ! Find out more
CYTK icon

Cytokinetics

134 hedge funds and large institutions have $502M invested in Cytokinetics in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 70 increasing their positions, 23 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

671% more call options, than puts

Call options by funds: $7.07M | Put options by funds: $917K

204% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 23

55% more capital invested

Capital invested by funds: $324M → $502M (+$178M)

4.5% more ownership

Funds ownership: 72.87%77.37% (+4.5%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

3% less funds holding

Funds holding: 138134 (-4)

11% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 18

Holders
134
Holders Change
-4
Holders Change %
-2.9%
% of All Funds
2.91%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
16
Increased
70
Reduced
23
Closed
18
Calls
$7.07M
Puts
$917K
Net Calls
+$6.15M
Net Calls Change
+$5.98M
Name Holding Trade Value Shares
Change
Change in
Stake
MIM
76
MetLife Investment Management
New Jersey
$296K +$73.6K +7,632 +41%
State Board of Administration of Florida Retirement System
77
State Board of Administration of Florida Retirement System
Florida
$295K +$6.56K +680 +3%
Dimensional Fund Advisors
78
Dimensional Fund Advisors
Texas
$281K
ProShare Advisors
79
ProShare Advisors
Maryland
$263K -$17.1K -1,769 -7%
OPERF
80
Oregon Public Employees Retirement Fund
Oregon
$258K +$16.4K +1,700 +8%
UBS Group
81
UBS Group
Switzerland
$242K +$160K +16,569 +334%
AC
82
Athanor Capital
New York
$242K +$207K +21,500 New
Federated Hermes
83
Federated Hermes
Pennsylvania
$241K +$193K +20,004 +1,379%
VOYA Investment Management
84
VOYA Investment Management
Georgia
$238K +$10.4K +1,081 +5%
LSERS
85
Louisiana State Employees Retirement System
Louisiana
$237K +$9.64K +1,000 +5%
COPPSERS
86
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$222K +$9.57K +992 +5%
SOADOR
87
State of Alaska Department of Revenue
Alaska
$220K +$11.3K +1,170 +6%
MSA
88
Mason Street Advisors
Wisconsin
$217K +$16.4K +1,696 +10%
GIA
89
Granite Investment Advisors
New Hampshire
$208K
MERSOM
90
Municipal Employees' Retirement System of Michigan
Michigan
$194K +$11.9K +1,230 +8%
ECM
91
Everence Capital Management
Indiana
$184K
AG
92
Aperio Group
California
$183K +$157K +16,271 New
FCBT
93
First Citizens Bank & Trust
North Carolina
$179K -$3.45K -358 -2%
FCM
94
Flinton Capital Management
Pennsylvania
$176K
MLICM
95
Metropolitan Life Insurance Company (MetLife)
New York
$169K +$10.4K +1,075 +8%
TAM
96
Tyers Asset Management
Texas
$145K
HighTower Advisors
97
HighTower Advisors
Illinois
$143K +$714 +74 +0.6%
MFG
98
Magnus Financial Group
New York
$133K
RCM
99
Riverhead Capital Management
Delaware
$129K
ZIM
100
Zacks Investment Management
Illinois
$124K -$74.8K -7,757 -41%

CYTK Hedge Fund Activity: Q2 2019 in Review

134 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q2 2019, worth a combined $502M — up 55% from $324M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of CYTK and 16 opened new positions — a net loss of 2 holders — while 23 trimmed existing stakes and 70 added.

The largest buyer was Driehaus Capital Management, opening a new position worth an estimated $21.1M. The largest seller was Lansdowne Partners (UK), exiting entirely with an estimated $11.8M sold.

  • 134 institutional investors held Cytokinetics (CYTK) as of Q2 2019, down from 138 in Q1 2019.
  • Funds reported $502M of Cytokinetics stock for Q2 2019, up 55% quarter-over-quarter.
  • 16 funds opened new Cytokinetics positions in Q2 2019 and 18 closed out, a net change of -2 holders.
  • The largest Cytokinetics buyer in Q2 2019 was Driehaus Capital Management, an estimated $21.1M added.
  • The largest Cytokinetics seller in Q2 2019 was Lansdowne Partners (UK), an estimated $11.8M sold.

Based on aggregated 13F filings for Q2 2019.